tiprankstipranks
SWK Holdings Corporation (SWKH)
:SWKH
US Market
Holding SWKH?
Track your performance easily

SWK Holdings (SWKH) Earnings Dates, Call Summary & Reports

33 Followers

Earnings Data

Report Date
Mar 27, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
0.94
Last Year’s EPS
0.23
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 12, 2018
|
% Change Since: 0.80%
|
Next Earnings Date:Sep 19, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth in the finance receivables portfolio, successful transactions, and progress in resolving nonaccrual loans. However, concerns were raised about the increased nonaccrual loans impacting realized yield and the potential exit of a large shareholder. Overall, the company is optimistic about ending the year with a strong portfolio and achieving growth targets.
Company Guidance
In the SWK Holdings third-quarter 2024 earnings call, Jody Staggs, President and CEO, provided guidance that highlighted several key financial metrics and strategic actions. The core finance segment generated $5 million in adjusted non-GAAP net income, with the gross finance receivables portfolio increasing 15% year-over-year to $270 million. The portfolio's effective yield improved by 60 basis points to 14.6%, while segment revenue rose 13.5% year-over-year to $10 million. Despite an increase in nonaccrual loans, positive developments in this area are expected to revert realized yields to historical trends. During the quarter, SWK closed an $11 million royalty monetization deal with Relief Therapeutics and a $26 million upsized amendment with Eton Pharmaceuticals. Furthermore, SWK anticipates closing an $8 million term loan by year-end. The company is focused on deploying capital into life science term loans and royalties, aiming for a 10% growth in tangible book value per share in 2025.
Increased Finance Receivables Portfolio
The gross finance receivables portfolio increased 15% year-over-year to $270 million, with a third quarter portfolio effective yield improving by 60 basis points year-over-year to 14.6%.
Revenue Growth
Segment revenue increased 13.5% year-over-year to $10 million with a realized yield of 13.8%.
Successful Transactions and Deals
Closed an up to $11 million royalty monetization with Relief Therapeutics and a $26 million upsized amendment to Eton Pharmaceuticals.
Enteris Division Progress
Enteris division's revenue doubled to $600,000 this quarter, with fourth quarter quarter-to-date bookings at an all-time high.
Resolution of Nonaccruals
Significant progress made in working out three nonaccrual names, including Exeevo and BIOLASE, without expected impairments.
---

SWK Holdings (SWKH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SWKH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Sep 19, 20182018 (Q2)
- / 0.28
0.267.69% (+0.02)
Nov 12, 20182018 (Q3)
- / -0.44
0.21-308.57% (-0.65)
Mar 29, 20192018 (Q4)
- / 0.36
-0.64155.63% (+1.00)
May 15, 20192019 (Q1)
- / 0.51
0.2881.43% (+0.23)
Aug 12, 20192019 (Q2)
- / 0.34
0.2819.64% (+0.05)
Nov 18, 20192019 (Q3)
- / 0.32
-0.438173.52% (+0.76)
Mar 30, 20202019 (Q4)
- / 0.37
0.3563.93% (+0.01)
May 14, 20202020 (Q1)
- / 0.21
0.508-58.66% (-0.30)
Aug 17, 20202020 (Q2)
- / 0.07
0.335-79.10% (-0.27)
Nov 13, 20202020 (Q3)
- / 0.34
0.3225.59% (+0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SWKH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 14, 2024$16.26$16.10-0.98%
Aug 15, 2024$16.83$16.94+0.65%
May 15, 2024$17.65$17.36-1.64%
Mar 21, 2024$17.96$17.89-0.39%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does SWK Holdings Corporation (SWKH) report earnings?
SWK Holdings Corporation (SWKH) is schdueled to report earning on Mar 27, 2025, TBA Not Confirmed.
    What is SWK Holdings Corporation (SWKH) earnings time?
    SWK Holdings Corporation (SWKH) earnings time is at Mar 27, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SWKH EPS forecast?
          SWKH EPS forecast for the fiscal quarter 2024 (Q4) is 0.94.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis